The European Union orders Moderna an additional 150 million doses of COVID-19 vaccine
With this new agreement, the European Union (EU) has bought 2.6 billion doses of vaccine from 6 vaccine manufacturers while the EU’s population is 450 million people.
The European Commission (EC) – the executive body of the European Union (EU) announced it had reached an agreement to buy 150 million more doses of COVID-19 vaccine from Moderna pharmaceutical company (USA) this year, up nearly twice as many doses of vaccine the EC is registering to buy from this US biotechnology company for 2021.
Under the agreement, the EU has the option to purchase another 150 million doses of Moderna’s vaccine for 2022.
The EU has ordered 160 million doses of Moderna’s vaccine for this year. Shipments began in January 2021, with a target of 10 million doses by the end of next March, although some vaccine deliveries have been delayed.
The EC said that with the new agreement, the EU has purchased 2.6 billion doses of vaccine from six vaccine manufacturers while the EU’s population is 450 million people.
Speaking at the press conference, EC President Ursula von der Leyen said the agreement brought the EU closer to its primary goal of ensuring that all people in the bloc had access to COVID-19 vaccine as soon as possible. Safe and effective.
Also on 17/2, India announced it would provide COVID-19 vaccine to all employees of the United Nations peacekeeping force, ie nearly 95,000 soldiers from 12 missions around the world.
Speaking at a meeting of the United Nations Security Council on the COVID-19 pandemic and conflict areas, Indian Foreign Minister Subrahmanyam Jaishankar said: “We would like to present a gift of 200,000 doses of vaccine to UN peacekeepers are working in difficult circumstances “.
Earlier in February, Indian officials said the country was working on developing seven more COVID-19 vaccines, in addition to Covishield vaccine of AstraZeneca (UK) and Covaxin of this country. Of the 7 vaccines mentioned above, 3 are in the experimental stage and 2 are in the pre-clinical stage.